How we explain hereditary cancer genetics
Every guide on PROMPT Study is built mechanism-first, grounded in peer-reviewed and clinical literature, and written to be accurate in two directions at once — plain enough for a worried patient, precise enough for a genetic counselor.
Editorial Standards & Sourcing
Mechanism before conclusion
We start with how a thing works, not with what to think about it. When we describe multi-gene panel testing, we explain what a panel sequences, how a variant is classified, and why a result may read as pathogenic, benign, or of uncertain significance — before we ever discuss what that result might mean for care. The goal is understanding that holds up: a reader who follows the mechanism can interpret a new result, a second opinion, or an updated guideline on their own.
This is the cadence of a respected academic medical center's patient-education library, not a marketing page. We cite how genetics works rather than asserting outcomes, and we leave room for the genuine uncertainty that defines this field.
How a guide gets written
Each explainer moves through the same disciplined path before it publishes.
Anchor to the source literature
We begin from peer-reviewed and clinical sources — registry findings, professional-society guidance, and genetic-counseling literature — not from secondary summaries or unverifiable claims.
Reconstruct the mechanism
We map how the process actually works, from the sample to the sequence: collection, extraction, sequencing, variant calling, and classification. The biology drives the explanation.
Translate without distorting
We render the mechanism in plain language while preserving the qualifications that matter — variants of uncertain significance, penetrance, and the limits of what a test result can and cannot tell you.
Separate education from advice
We draw an explicit line between explaining a topic and recommending a course of action. Guides inform a conversation with a clinician; they never replace it.
No fabricated claims, no invented authority
We do not invent providers, reviews, testimonials, or statistics, and we do not present commercial products as clinical recommendations. Where a number or finding appears, it traces to published research. Where evidence is mixed or evolving — as it often is in hereditary cancer genetics — we say so plainly rather than manufacturing false certainty.
PROMPT Study grew out of a real multi-institutional registry tracking patients who underwent multi-gene panel testing. That history sets the standard we hold ourselves to: longitudinal, evidence-minded, and honest about what is still unknown.
Frequently asked questions
Is anything on this site medical advice?
No. Our content is educational reference material about hereditary cancer genetics, panel testing, and patient registries. It is designed to help you understand mechanisms and ask better questions — not to diagnose, recommend testing, or guide treatment. Decisions about genetic testing and care belong with a qualified clinician or genetic counselor who knows your personal and family history.
What kinds of sources do you rely on?
Peer-reviewed journals, clinical and registry findings, professional-society guidance, and established genetic-counseling literature. We favor primary sources over summaries and avoid claims that cannot be traced to published evidence.
How do you handle scientific uncertainty?
We name it. Variant interpretation evolves, penetrance estimates vary, and a result can be genuinely ambiguous — for example, a variant of uncertain significance. We explain that uncertainty rather than smoothing it over, because misrepresenting confidence would undermine the trust both patients and clinicians place in this material.
Do you sell tests, kits, or products?
No. During this phase, PROMPT Study is an independent educational knowledge hub. We describe how genetic samples are collected and processed — saliva kits, buccal swabs, blood draws — for understanding, not as products, and we do not funnel readers toward any commercial destination.
Who is this written for?
Two audiences at once: patients and families weighing hereditary-cancer testing, and the clinicians, genetic counselors, and students who use the material as reference. We write to be readable for the former and precise enough for the latter.
Have a question about how we source a guide?
We are glad to explain our editorial process, point you to the underlying literature, or hear where a guide could be clearer. Accuracy is a conversation, and we welcome it.